Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma News

  • Obinutuzumab vs Rituximab in FL: 'Too Close to Call' Obinutuzumab for induction and maintenance provides significantly higher PFS than rituximab, the current standard of care for follicular lymphoma (FL). But an editorial cautions it's too soon to tell.
  • Reaction to 'Old' Tattoo Ink Mimics Lymphoma An unusual case of tattoo pigment hypersensitivity caused widespread lymphadenopathy 15 years later, but without a skin reaction.

Non-Hodgkin's Lymphoma Perspective